By regulating the interaction between YAP1 and the cGAS-STING pathway, we demonstrate that inhibition of YAP1 can overcome immune suppression and enhance anti-tumor immunity, offering new therapeutic strategies for HCC treatment. This evidence concerns the gene CGAS and hepatocellular carcinoma.